Skip to content

Author

M. Ciaccio

We have 5 of 366 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity.

AIMS/HYPOTHESIS Obesity drives cardiometabolic dysfunction and increases cardiovascular risk, with excess fat mass and impaired body composition playing a key role in metabolic outcomes. This clinical study aimed to evaluate the real-world effectiveness (RWE) of tirzepatide on body weight, body composition, and metabol...

Davide Brancato, V. Maggio, Francesca Vaccaro et al. · 0 citations
Open access Sep 2026

Effects of Glucoerb® and Epavin® on Cardiometabolic Profile in Adults with Overweight or Obesity: A Three-Month Real-World Study

Background/Objectives: Overweight and obesity are major drivers of cardiometabolic dysfunction and increase the risk of type 2 diabetes (T2DM)and cardiovascular disease. Although lifestyle intervention remains the cornerstone of treatment, complementary strategies may provide additional benefits. The effects of Glucoer...

V. Maggio, Francesca Vaccaro, Elena Muratore et al. · 0 citations
Review Open access Aug 2026

Endothelial Dysfunction and Obesity: New Diagnostic and Therapeutic Strategies

The evidence supports an integrated and personalized management strategy targeting both metabolic and vascular abnormalities to reduce cardiovascular risk and improve long-term clinical outcomes in individuals with obesity.

R. V. Giglio, S. Stanković, Angelo M. Patti et al. · 0 citations
Sep 2026

Toward harmonized reporting of Alzheimer’s disease biomarkers in clinical practice

The principles of harmonized reporting for Alzheimer’s disease biomarkers and a structured framework for standardized clinical neurochemistry reports are discussed and a structured framework for standardized clinical neurochemistry reports is proposed.

L. Agnello, Andrea Pilotto, L. Gaetani et al. · 0 citations
Open access Sep 2026

Assessing the Clinical Relevance of Blood Soluble Triggering Receptor Expressed on Myeloid Cells 2 in Neurological Diseases

Blood sTREM2 does not directly mirror central nervous system microglial activation but may reflect peripheral immune dynamics, warranting further investigation into its role as a biomarker of systemic immune dysfunction in neurodegenerative diseases.

L. Agnello, C. Gambino, Giuseppe Salemi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.